Close Menu

NEW YORK (GenomeWeb) – Multi-gene germline testing of breast cancer patients doubles the detection of disease-causing variants that could result in a change of care, compared to BRCA1- and BRCA2-only testing, though it does not increase prophylactic breast removal, according to a large new retrospective population-based study.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.


This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.